Sfoglia per AUTORE
OLIVA EN
Collezione AOU Alessandria

  

Items : 3

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.
2023
AOU Alessandria
AOU Città della Salute di Torino

Zini G; D'Errigo MG; Bova I; Rizzo L; Cufari P; Delfino IM; Arcadi MT; Candoni A; Liberati AM; Stamatoullas-Bastard A; Rivellini F; Buccisano F; Di Renzo N; Impera S; Palumbo GA; Germing U; Ricco A; Fenaux P; Molteni A; Bocchia M; Fattizzo B; Beltrami G; Castelli A; Russo E; Tripepi G; Iannì G; Guarini A; Ferrero D; Cascavilla N; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.
2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino

Della Porta MG; Santini V; Naldi I; Pasini P; Giordano L; Finelli C; Turrini M; Sancetta R; Selleri C; Tanasi I; Tosi P; Frigeni M; Marchetti M; Norata M; Grimaldi D; Fianchi L; Galimberti S; Ferrara F; Castelli A; Di Bona E; Di Veroli A; Bono R; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 May 1;39(13):1426-1436. doi: 10.1200/JCO.20.02619. Epub 2021 Mar 25.
2021
AOU Alessandria

Garcia-Manero G; Santini V; Almeida A; Platzbecker U; Jonasova A; Silverman LR; Falantes J; Reda G; Buccisano F; Fenaux P; Buckstein R; Diez Campelo M; Larsen S; Valcarcel D; Vyas P; Giai V; Olíva EN; Shortt J; Niederwieser D; Mittelman M; Fianchi L; La Torre I; Zhong J; Laille E; Lopes de Menezes D; Skikne B; Beach CL; Giagounidis A;